
News|Videos|March 5, 2026
Expert panel: Navigating shifts in maternal immunization guidance
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Benjamin P. Saylor
An expert infectious disease panel discusses how recent federal vaccine schedule changes can impact maternal immunizations and potential repercussions.
Advertisement
Advertisement
As the healthcare community adjusts to several federal vaccine recommendation changes from the CDC’s Advisory Committee on Immunization Practices (ACIP), many professionals have expressed frustration and confusion. Changes—including the move to “shared clinical decision-making” and the re-categorization of certain vaccines—have sent ripples through the industry, leading some providers to prioritize long-standing medical society recommendations over shifting federal guidance.
Related to this article

Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.

Drawing on her own successful version, Amber Watters, MD, welcomes the ASA's push for closer obstetrics and anesthesia collaboration.

SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.

Kevin Ault, MD, FACOG, explains that all four vaccines in ACOG's 2026-27 guidance carry direct newborn benefit and that prenatal conversations ease downstream pediatric vaccine discussions.

Kevin Ault, MD, FACOG, emphasizes that obstetric clinicians are patients' most trusted vaccine information source, making maternal COVID-19 counseling a high-value opportunity.

FDA granted BTD to certolizumab pegol for preventing adverse pregnancy outcomes in women with antiphospholipid syndrome.

Amber Watters, MD, MS, explains how the ASA's statement encourages obstetric units to integrate neuraxial anesthesia into a formal external cephalic version process.
Advertisement
Advertisement

